These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20460573)

  • 21. Use of oxytocin to prevent haemorrhage at caesarean section--a survey of practice in the United Kingdom.
    Wedisinghe L; Macleod M; Murphy DJ
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):27-30. PubMed ID: 17544563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive monitoring of the cardiac effects of continuous intravenous oxytocin infusion during cesarean delivery.
    Tanaka H; Tanaka K; Tsuji M; Magawa S; Hatano F; Nii M; Ikeda T
    Int J Gynaecol Obstet; 2017 Nov; 139(2):251-252. PubMed ID: 28833080
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison the effects of oxytocin and methylergonovine in elective caesarean section under spinal anesthesia.
    Anvaripour A; Shahryari H; Ahmadi S; Ghasemi S; Mirzaei K
    Arch Gynecol Obstet; 2013 May; 287(5):979-83. PubMed ID: 23250341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxytocin use during Caesarean sections in Denmark - are we getting the dose right?
    Kjaer BN; Krøigaard M; Garvey LH
    Acta Anaesthesiol Scand; 2016 Jan; 60(1):18-25. PubMed ID: 26338081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimum oxytocin dose requirement after cesarean delivery for labor arrest.
    Balki M; Ronayne M; Davies S; Fallah S; Kingdom J; Windrim R; Carvalho JC
    Obstet Gynecol; 2006 Jan; 107(1):45-50. PubMed ID: 16394038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.
    George RB; McKeen D; Chaplin AC; McLeod L
    Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbetocin versus oxytocin to reduce additional uterotonic use at non-elective caesarean section: a double-blind, randomised trial (.).
    Whigham CA; Gorelik A; Loughnan TE; Trivedi A
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3866-9. PubMed ID: 26940081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of guidelines on oxytocin use at caesarean section: a survey of practice in Great Britain and Ireland.
    Sheehan SR; Wedisinghe L; Macleod M; Murphy DJ
    Eur J Obstet Gynecol Reprod Biol; 2010 Feb; 148(2):121-4. PubMed ID: 19896761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood loss after caesarean section: depending on the management of oxytocin application?
    Pursche T; Diedrich K; Banz-Jansen C
    Arch Gynecol Obstet; 2012 Sep; 286(3):633-6. PubMed ID: 22569708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial.
    Page GH
    BJOG; 2010 Dec; 117(13):1665; author reply 1665-6. PubMed ID: 21078062
    [No Abstract]   [Full Text] [Related]  

  • 31. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose.
    Cordovani D; Balki M; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2012 Aug; 59(8):751-7. PubMed ID: 22717890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomised controlled trial of early versus delayed oxytocin augmentation to treat primary dysfunctional labour in nulliparous women.
    Hinshaw K; Simpson S; Cummings S; Hildreth A; Thornton J
    BJOG; 2008 Sep; 115(10):1289-95; discussion 1295-6. PubMed ID: 18715415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial.
    Attilakos G; Psaroudakis D; Ash J; Buchanan R; Winter C; Donald F; Hunt LP; Draycott T
    BJOG; 2010 Jul; 117(8):929-36. PubMed ID: 20482535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbetocin at elective Cesarean delivery: a sequential allocation trial to determine the minimum effective dose.
    Khan M; Balki M; Ahmed I; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2014 Mar; 61(3):242-8. PubMed ID: 24281981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section.
    Eftekhari N; Doroodian M; Lashkarizadeh R
    J Obstet Gynaecol; 2009 Oct; 29(7):633-6. PubMed ID: 19757270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2.
    Anandakrishnan S; Balki M; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2013 Nov; 60(11):1054-60. PubMed ID: 24158878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum oxytocin concentrations in elective caesarean delivery: a randomized comparison of three infusion regimens.
    Yamaguchi ET; Cardoso MM; Torres ML; Nascimento RC; Ribeiro MC; Frerichs E; Payen D
    Int J Obstet Anesth; 2011 Jul; 20(3):224-8. PubMed ID: 21641198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized double-blind comparison of the effects of intramyometrial and intravenous oxytocin during elective cesarean section.
    Akinaga C; Uchizaki S; Kurita T; Taniguchi M; Makino H; Suzuki A; Uchida T; Suzuki K; Itoh H; Tani S; Sato S; Terui K
    J Obstet Gynaecol Res; 2016 Apr; 42(4):404-9. PubMed ID: 26786149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbetocin versus oxytocin after caesarean section: similar efficacy but reduced pain perception in women with high risk of postpartum haemorrhage.
    De Bonis M; Torricelli M; Leoni L; Berti P; Ciani V; Puzzutiello R; Severi FM; Petraglia F
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):732-5. PubMed ID: 21761999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial.
    Jonsson M; Hanson U; Lidell C; Nordén-Lindeberg S
    BJOG; 2010 Jan; 117(1):76-83. PubMed ID: 19781043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.